Cargando…

Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype

Detalles Bibliográficos
Autores principales:	Kresbach, Catena, Dorostkar, Mario M., Suwala, Abigail K., Wefers, Annika K., Schweizer, Leonille, Engertsberger, Lara, Bison, Brigitte, Mynarek, Martin, Kloth-Stachnau, Katja, Spohn, Michael, von Deimling, Andreas, Benesch, Martin, Hagel, Christian, Mautner, Viktor-F., Rutkowski, Stefan, Schüller, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113165/ https://www.ncbi.nlm.nih.gov/pubmed/33844070 http://dx.doi.org/10.1007/s00401-021-02304-4

Ejemplares similares

EPEN-27. Epigenetic dissection of spinal ependymomas (SP-EPN) separates tumors with and withoutNF2 mutation
por: Neyazi, Sina, et al.
Publicado: (2022)

EPEN-04. Refinement of molecular and clinical characteristics in a cohort of 1,801 ependymomas
por: Pohl, Lara, et al.
Publicado: (2022)

EPEN-09. IMPACT OF MOLECULAR SUBGROUP ON OUTCOME FOR INFANTS <12 MONTHS WITH INTRACRANIAL EPENDYMOMA - GERMAN EXPERIENCE FROM HIT2000, INTERIM-2000-REGISTRY AND I-HIT-MED REGISTRY
por: Obrecht, Denise, et al.
Publicado: (2020)

HGG-45. Characterization of spinal diffuse midline gliomas, H3 K28M-mutant
por: Stegat, Lotte, et al.
Publicado: (2022)

MEDB-16. Persistent radiological lesions at the end of primary therapy in childhood medulloblastoma: residual lesion or active residual tumor?
por: Schömig, Lena, et al.
Publicado: (2022)

Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
por: Adolph, Jonas E., et al.
Publicado: (2021)

EPEN-39. CLINICAL STRATIFIED TREATMENT OF LOCALIZED PEDIATRIC INTRACRANIAL EPENDYMOMA WITH COMBINED LOCAL IRRADIATION AND CHEMOTHERAPY WITHIN THE PROSPECTIVE, MULTICENTER E-HIT TRIAL – THE MOLECULAR SUBGROUP MATTERS
por: von Hoff, Katja, et al.
Publicado: (2020)

Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort
por: Kloth, Katja, et al.
Publicado: (2021)

Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts
por: Mynarek, Martin, et al.
Publicado: (2022)

Long-term survival of an adolescent glioblastoma patient under treatment with vinblastine and valproic acid illustrates importance of methylation profiling
por: Kresbach, Catena, et al.
Publicado: (2021)

Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies
por: Obrecht, Denise, et al.
Publicado: (2022)

Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome
por: Jünger, Stephanie T., et al.
Publicado: (2020)

RARE-12. Pineoblastoma of children and young adults in a national population: An analysis of the HIT-MED study cohort
por: Yuan, Mathias, et al.
Publicado: (2022)

Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond
por: Kresbach, Catena, et al.
Publicado: (2022)

QOL-13. NEUROCOGNITIVE OUTCOMES ACCORDING TO RISK-ADAPTED TREATMENT REGIMENS FOR CHILDREN OLDER THAN 4 WITH MEDULLOBLASTOMA AND POSTERIOR FOSSA EPENDYMOMA – RESULTS OF THE HIT2000 TRIAL
por: Mynarek, Martin, et al.
Publicado: (2020)

MEDB-41. Identifying a subgroup of patients with early childhood sonic hedgehog-activated medulloblastoma with unfavorable prognosis after treatment with radiation-sparing regimens including intraventricular methotrexate
por: Tonn, Svenja, et al.
Publicado: (2022)

A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma
por: Ng, Chia Huan, et al.
Publicado: (2023)

MODL-03. Establishment of intraventricular Shh inhibition as a therapeutic option for young patients with medulloblastoma
por: Kresbach, Catena, et al.
Publicado: (2022)

MBCL-09. ISOLATED M1 METASTASES IN PEDIATRIC MEDULLOBLASTOMA: IS POSTOPERATIVE RADIOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY SUPERIOR TO POSTOPERATIVE SANDWICH-CHEMOTHERAPY AND RADIOTHERAPY?
por: Obrecht, Denise, et al.
Publicado: (2020)

EPEN-27. CDKN2A DELETION IN SUPRATENTORIAL EPENDYMOMA WITH RELA ALTERATION INDICATES A DISMAL PROGNOSIS – A RETROSPECTIVE ANALYSIS OF THE HIT EPENDYMOMA TRIAL COHORT
por: Jünger, Stephanie T, et al.
Publicado: (2020)

MEDB-11. MYC overexpression and SMARCA4 loss in cerebellar granule cell precursors cooperate to drive medulloblastoma formation in mice
por: Göbel, Carolin, et al.
Publicado: (2022)

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohort
por: Jünger, Stephanie T., et al.
Publicado: (2019)

CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort
por: Jünger, Stephanie T., et al.
Publicado: (2020)

EPEN-36. THE TREATMENT OUTCOME OF PAEDIATRIC SUPRATENTORIAL C11ORF95-RELA FUSED EPENDYMOMA: A COMBINED REPORT FROM E-HIT SERIES AND AUSTRALIAN NEW ZEALAND CHILDREN’S HAEMATOLOGY/ONCOLOGY GROUP
por: Ng, Chia Huan, et al.
Publicado: (2020)

Supratentorial ependymoma in childhood: more than just RELA or YAP
por: Zschernack, Valentina, et al.
Publicado: (2021)

MEDB-37. Chemotherapy response prediction by molecular risk factors in metastatic childhood medulloblastoma
por: Obrecht, Denise, et al.
Publicado: (2022)

Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome
por: Schoof, Melanie, et al.
Publicado: (2021)

TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma
por: Thomas, Christian, et al.
Publicado: (2021)

MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice
por: Göbel, Carolin, et al.
Publicado: (2023)

MEDB-51. Impact of residual tumor on outcomes in children and adolescents with medulloblastoma in the German HIT-cohort
por: Wolgast, Stella, et al.
Publicado: (2022)

Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma
por: Begemann, Matthias, et al.
Publicado: (2020)

Ependymomas
por: Bertero, Luca, et al.
Publicado: (2022)

Unilateral gynaecomastia in a 16-month-old boy with neurofibromatosis type 1 – case report and brief review of the literature
por: Friedrich, Reinhard E., et al.
Publicado: (2015)

Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study
por: Peters, Sarah, et al.
Publicado: (2021)

Sacrococcygeal myxopapillary ependymoma with anaplastic ependymoma component in an infant
por: Chakraborti, Shrijeet, et al.
Publicado: (2012)

PATH-04. Array-based global DNA Methylation profiling of mouse brain tumors allows comparison to human tumors
por: Schoof, Melanie, et al.
Publicado: (2022)

Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
por: Schoof, Melanie, et al.
Publicado: (2023)

EPEN-03. ZFTA/C11ORF95 FUSIONS DRIVE SUPRATENTORIAL EPENDYMOMA VIA SHARED ONCOGENIC MECHANISMS
por: Zheng, Tuyu, et al.
Publicado: (2021)

D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma
por: Pusch, Stefan, et al.
Publicado: (2014)

ETMR-14. TREATMENT OF EMBRYONAL TUMOURS WITH MULTILAYERED ROSETTES (ETMR) WITH CARBOPLATIN-ETOPOSIDE INDUCTION AND TANDEM HIGH-DOSE CHEMOTHERAPY WITHIN THE PROSPECTIVE HIT-TRIALS AND REGISTRIES
por: Juhnke, Björn-Ole, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oddf1dkgsjgq7q508iri4vnsgh